CDX2 and neoplasm: In this study, we evaluated the immunohistochemical expression of caudal-related homeobox transcription factor 2 (CDX2) in a large cohort of >1000 CRCs and correlated the results with staging parameters, microsatellite status and morphological parameters defined by the recent WHO classification (CRC subtypes, tumour budding, WHO grade).